Emergent Biosolutions: Q1 Earnings Snapshot
By AP News
Published - May 09, 2023, 05:12 PM ET
Last Updated - Jun 21, 2023, 09:22 PM EDT
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Tuesday reported a loss of $183 million in its first quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $3.65. Losses, adjusted for non-recurring costs, were $3.17 per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.67 per share.
The biopharmaceutical company posted revenue of $165.1 million in the period.
